FOR IMMEDIATE RELEASE August 21, 2020, 1:00 pm EDT Contact: John M. Clymer Executive Director 202-903-7303 More Patient Groups Appeal to Congress to Fix Glitch So Americans Have Access to COVID and Flu Testing and Vaccinations Patient groups urging action in next COVID bill represent 200 million …
A Real Way to Strengthen the U.S. Response to COVID-19 That’s Ready to Roll
John M. Clymer Executive Director National Forum for Heart Disease & Stroke Prevention As Congress and the Trump Administration negotiate over the next COVID-19 legislative package, they have an opportunity to strengthen the nation’s response to the pandemic, blunt the health impact of COVID-19 and, at the same time, increase health …
National Forum and Partners Call on Congress and President to Expand Access to Care in COVID-19 Bill
EMBARGOED Until August 6, 2020, 12:30 pm EDT Contact: John M. Clymer Executive Director 202-903-7303 Patients, Consumers, the Underserved, Healthcare Providers and Public Health Call on Congress to Fix a Missing Link So Pharmacies Can Ramp Up COVID Testing and Prepare for Vaccinations Patient groups …
National Forum and Partners Urge Congress and Administration to Increase Patients’ Access to Healthcare, Team-Based Care
For release Tuesday, June 16, 2020, 12 pm EDT For information contact John M. Clymer, Executive Director, 202-903-7303 or john.clymer@nationalforum.org NATIONAL FORUM AND PARTNERS URGE CONGRESS AND ADMINISTRATION TO INCREASE PATIENTS’ ACCESS TO HEALTHCARE, TEAM-BASED CARE Today, the National Forum for Heart Disease & Stroke Prevention and …
Value & Access Steering Committee & Partners Provide Consensus Feedback on ICER Draft Scope of High Cholesterol Treatments
The National Forum’s Value & Access Initiative Steering Committee and partners engaged in the value & access space provided consensus feedback on the Institute for Clinical and Economic Review (ICER)’s draft scope of the assessment of the comparative clinical effectiveness and value of inclisiran (Novartis) and bempedoic acid (Nexletol™, …
Value & Access Steering Committee & Partners Provide Input on ICER Draft Scope of High Cholesterol Treatments
The National Forum’s Value & Access Initiative Steering Committee and partners engaged in the value & access space provided input on the Institute for Clinical and Economic Review (ICER)’s scope of the upcoming assessment of the comparative clinical effectiveness and value of inclisiran (Novartis) and bempedoic acid (Nexletol™, Esperion …
National Forum Statement about ICER’s Announced Assessment of New Cholesterol Medications
The National Forum released the following statement about the Institute for Clinical and Economic Review’s (ICER’s) announcement today that it will conduct value assessments of inclisiran and bempadoic acid, two new treatments for high cholesterol. The Value & Access Steering Committee (VASC), convened by the National Forum and representing …
Value & Access Steering Committee & Partners Comment on ICER Draft Evidence Report on Additive CVD Therapies
The National Forum submitted to the Institute for Clinical and Economic Review (ICER) feedback from the Value & Access Steering Committee and partners on ICER’s Draft Evidence Report on Additive Cardiovascular Disease Therapies. The feedback reflects the consensus of Value & Access Steering Committee members and partners who represent …
National Forum for Heart Disease & Stroke Prevention Announces New Chair of Value & Access Initiative
FOR IMMEDIATE RELEASE National Forum for Heart Disease & Stroke Prevention Announces New Chair of Value & Access Initiative WASHINGTON, DC, July 25, 2019 – The National Forum for Heart Disease & Stroke Prevention announced that Michael Cropp, MD, MBA, President & CEO of Independent Health will serve as the Chair of the …